.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Moodys
US Department of Justice
Covington
Medtronic
Express Scripts
McKesson
Queensland Health
Baxter
Cantor Fitzgerald

Generated: June 25, 2017

DrugPatentWatch Database Preview

PENBRITIN-S Drug Profile

« Back to Dashboard

Which patents cover Penbritin-s, and what generic Penbritin-s alternatives are available?

Penbritin-s is a drug marketed by Wyeth Ayerst and is included in one NDA.

The generic ingredient in PENBRITIN-S is ampicillin sodium. There are sixty-nine drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ampicillin sodium profile page.

Summary for Tradename: PENBRITIN-S

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list29
Patent Applications: see list8,850
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PENBRITIN-S at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst
PENBRITIN-S
ampicillin sodium
INJECTABLE;INJECTION050072-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Wyeth Ayerst
PENBRITIN-S
ampicillin sodium
INJECTABLE;INJECTION050072-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Wyeth Ayerst
PENBRITIN-S
ampicillin sodium
INJECTABLE;INJECTION050072-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Wyeth Ayerst
PENBRITIN-S
ampicillin sodium
INJECTABLE;INJECTION050072-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Wyeth Ayerst
PENBRITIN-S
ampicillin sodium
INJECTABLE;INJECTION050072-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
UBS
Accenture
Novartis
Deloitte
Colorcon
Fish and Richardson
Boehringer Ingelheim
US Army
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot